Physician profile
Ryan Duvall
NPI 1841428075
$646.98
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $613 · 2020: $34.25.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $169.06 | 2019 | |
| Medtronic Minimed, INC. | $120.38 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $82.27 | 2019 | |
| Sanofi-Aventis U.S. LLC | $50.77 | 2019 | |
| Merck Sharp & Dohme LLC | $49.26 | 2019-2020 | |
| Grifols USA, LLC | $38.74 | 2019 | |
| Sanofi Pasteur INC. | $34.64 | 2019 | |
| Pfizer INC. | $28.52 | 2019 | |
| Mallinckrodt Enterprises LLC | $23.27 | 2019 | |
| Mallinckrodt Hospital Products INC. | $21.55 | 2020 | |
| Novo Nordisk INC | $15.91 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.61 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Duvall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.